Assessment of early metabolic progression in melanoma patients under immunotherapy: an (18)F-FDG PET/CT study

BACKGROUND: The usage of immune checkpoint inhibitors (ICIs) is the standard practice for the treatment of metastatic melanoma. However, a significant amount of patients show no response to immunotherapy, while issues on its reliable response interpretation exist. Aim of this study was to investigat...

Descripción completa

Detalles Bibliográficos
Autores principales: Sachpekidis, Christos, Kopp-Schneider, Annette, Hassel, Jessica C., Dimitrakopoulou-Strauss, Antonia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8426446/
https://www.ncbi.nlm.nih.gov/pubmed/34495433
http://dx.doi.org/10.1186/s13550-021-00832-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8426446/
https://www.ncbi.nlm.nih.gov/pubmed/34495433
http://dx.doi.org/10.1186/s13550-021-00832-4

Ejemplares similares